Puma Biotechnology to Present at Leerink Swann and Company Global Healthcare Conference

Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 4:00 p.m. EST on Wednesday, February 13, at the Leerink Swann Global Healthcare Conference 2013. The conference will be held at The Waldorf Astoria in New York.

Back to news